2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions

Jump to: View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 1607

B Cell and Neutrophil-Related Transcripts Predict and Characterize a Lupus Flare
Abstract Number: 1718

B Cell Subsets Homeostasis and Functional Properties Are Altered in a Murine Model of Systemic Sclerosis
Abstract Number: 2870

B Cell-Intrinsic Deletion of the Type 1 Interferon Receptor Does Not Impact the Development of Murine Lupus
Abstract Number: 2694

B Lymphocyte Stimulator (BLyS) Promotes Dysregulated Monocyte Function in Systemic Lupus Erythematosus(SLE)
Abstract Number: 2872

B-Cell Autoepitope and Tetramer Analysis Reveals Expansion of Apoptotic Autoantigen La and snRNP Reactive B Cells in BXD2 Mice
Abstract Number: 2734

B55β Regulates T Cell Survival through the Modulation of AKT during Cytokine Deprivation
Abstract Number: 2247

Bariatric Surgery Improves Quality of Life in Patients with Osteoarthritis and Obesity Compared to Non-Surgical Weight Loss
Abstract Number: L17

Bariatric Surgery Improves Rheumatoid Arthritis Disease Activity, Reduces Inflammatory Markers, and Decreases Medication Usage
Abstract Number: 1151

Barriers and Facilitators of a Career in Research Among Rheumatologists in the United States
Abstract Number: 1641

Baseline Factors That Predict High BLyS Levels in Patients with Systemic Lupus Erythematosus (SLE) and High Disease Activity
Abstract Number: 2134

Baseline Scintigraphic Detection of TNFá As a Predictor of Therapy Response after Treatment with Certolizumab Pegol in Rheumatoid Arthritis and Spondyloarthritis Patients
Abstract Number: 2927

Baseline Serum Interferon Beta/Alpha Ratio Predicts Response to Tumor Necrosis Factor Alpha Inhibition in Rheumatoid Arthritis
Abstract Number: 2839

BCL-2 As a Potential Therapeutic Target in Human Lupus Tubulointerstitial Inflammation
Abstract Number: 1212

Behcets Disease in Females Due to Mutation in NEMO, the NF-Kb Essential Modulator
Abstract Number: 671

Belimumab Reduces the Frequency of Flares in Patients with Refractory SLE: DATA from Clinical Practice Setting
Abstract Number: 7

Beneficial Effects of in Vivo Ubiquinol Supplementation on Athero-Thrombosis Prevention in Antiphospholipid Syndrome Patients
Abstract Number: 2103

Benefits of Early Onset of DAS28 (CRP) <2.6 on Physical Functioning, Quality of Life and Resource Use Among RA Patients in a Clinical Practice Setting
Abstract Number: 2313

Best Practices for Best Practice Alerts: Evaluation of a Best Practice Alert to Detect Chronic Glucocorticoid Use
Abstract Number: 2815

Better Functional Ability with Less Biologicals 2 years after Induction with Combination DMARD Therapy versus methotrexate Monotherapy
Abstract Number: 569

Better Outcomes in Ankylosing Spondylitis: The Synergistic Association Between Exercise and Tumor Necrosis Factor Inhibitors
Abstract Number: 1545

Better Performance of the Leeds and Sparcc Enthesitis Indices Compared to the Mases in Patients with Peripheral Spondyloarthritis during Treatment with Adalimumab
Abstract Number: 425

Beyond Disease Activity: Patient Global Scores Also Reflect Treatment Expectations and Emotional Reactions to Living with Rheumatoid Arthritis
Abstract Number: 2166

Bim Suppresses the Development of Glomerulonephritis By Inhibiting M2 Polarization
Abstract Number: 501

Bio-naïve Patients with Rheumatoid Arthritis Benefit More from Abatacept Treatment Compared to Those Who Are Inadequate Responders to Other Biologics – Results from the National Swedish Rheumatology Quality Register
Abstract Number: 1049

Bioactive TGF-β Is Present on Bovine Milk-Derived Exosomes: Consequences for Patients?
Abstract Number: 941

Biologic De-Escalation in Rheumatoid Arthritis: Cost Savings and Clinical Success
Abstract Number: 499

Biologic Discontinuation in Rheumatoid Arthritis: Experience from a Canadian Clinic
Abstract Number: 2036

Biologic Disease-Modifying Antirheumatic Drugs and Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Women with RA
Abstract Number: 115

Biologic Dmards Modify the Association Between Patient Expectations and Outcomes of Total Knee Replacement in Rheumatoid Arthritis Patients
Abstract Number: 2300

Biologic Treatment in Systemic Juvenile Idiopathic Arthritis: Single Center Experience
Abstract Number: 280

Biologic Treatment of Adult Patients with Juvenile Idiopathic Arthritis Followed in the National Registry
Abstract Number: 2514

Biological Treatment for Rheumatoid Arthritis (RA): A Fifteen Years Multicentric Overview
Abstract Number: 811

Biologics in Takayasu Arteritis: Preliminary Data from the French Registry
Abstract Number: 911

Bioluminescent Imaging of Histidyl-Transfer RNA Synthetase-Induced Myositis Reveals Early-Phase Involvement of NF-Kb-Mediated Inflammation
Abstract Number: 630

Biomarkers of Bone Remodeling Are Elevated in Psoriatic Arthritis
Abstract Number: 373

Biomarkers of Cardiac Dysfunction and Inflammation in Plasma Predict Occult Coronary Plaque Burden and Composition in Rheumatoid Arthritis
Abstract Number: 629

Biomarkers of Chondrocyte Activity Are Increased in Psoriasis Arthritis and Spondyloarthritis
Abstract Number: 808

Biomarkers of Disease Activity in Vasculitis
Abstract Number: 1652

Biomarkers of Lupus Nephritis and Ethnic Disparities in Systemic Lupus Erythematosus
Abstract Number: 1866

Birth Outcomes in Women with a History of Juvenile Idiopathic Arthritis
Abstract Number: 831

Bisphosphonates and Risk of Acute Pseudogout: A Case-Control Study in the Clinical Practice Research Datalink (CPRD)
Abstract Number: 588

Blacks with As Have Greater Disease Severity Than Whites
Abstract Number: 2795

Blockade of IL-6R Signaling by Sarilumab Suppressed Circulating Markers of Bone Resorption and Synovial Damage in Rheumatoid Arthritis Patients from a Phase 3, Randomized, Double-Blind, Placebo-Controlled, International Study
Abstract Number: 1899

Blockade of Interleukin-33 Signaling Prevents Death in a Mouse Model of Familial Hemophagocytic Lymphohistiocytosis
Abstract Number: 965

Blockade of TLR4 Signaling By TAK242 Ameliorates Experimental Organ Fibrosis
Abstract Number: 1510

Blockade of TLR5 Ligation Is a Novel Strategy for RA Therapy
Abstract Number: 2194

Blue Digit Syndrome: The Rheumatologist’s Perspective
Abstract Number: 2793

BMP2 Requires TGF-Beta to Induce Osteophytes during Experimental Osteoarthritis
Abstract Number: 1017

BMP9-Induced pSmad1/5/8 Signaling and Chondrocyte Hypertrophy Are Effectively Inhibited By TGFβ1
Abstract Number: 45

Body Mass Index Across the Lifespan and Lifetime Incidence of Gout in Men
Abstract Number: 338

Bombina Variegate peptide8/Prokineticin 2: A Novel Arthritis-Inducible Chemokine
Abstract Number: 1424

Bone Erosions in Patients with RA: Exploring the Impact of the Anatomy of Interest on the Relationship Between MRI and X-Ray Erosion Detection
Abstract Number: 2130

Bone Microstructure in Patients with Cutaneous Psoriasis and No History of Psoriatic Arthritis Shows Bone Anabolic Changes at a Greater Extent Than in Healthy Controls
Abstract Number: 1683

Botulinum Toxin-a for the Treatment of Severe Raynaud Phenomenon
Abstract Number: L20

BOW015, a Biosimilar Infliximab, in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses: 54-Week Results of a Randomized, Double-Blind, Active Comparator Study
Abstract Number: 2657

Brain Gray and White Matter Volume Losses and Their Associations with Glucocorticoid Use in Patients with Newly Diagnosed Systemic Lupus Erythematosus (SLE) – a Prospective MR Study
Abstract Number: 656

Breach of B Cell Tolerance in New Zealand Black Chromosome 1 Congenic Mice
Abstract Number: 2871

Break of Anergy in Human Autoreactive B Cells By T Helper Signals Restores B Cell Receptor Signaling Capacity and Is Dependent on Upregulation of CD45 Phosphatase Activity-a Possible Novel Mechanism of Breech of B Cell Tolerance in Rheumatic Diseases
Abstract Number: 659

Breakdown of Tolerance at the Tissue Level in Systemic Autoimmunity: Role of Tissue-Resident Dendritic Cells
Abstract Number: 1333

Bridging the Social Support Needs Gap for African American Women with Systemic Lupus Erythematosus through the Chronic Disease Self-Management Program
Abstract Number: 1728

Bromodomain Inhibitor JQ1 Modulates Collagen Processing and Ameliorates Bleomycin Induced Dermal Fibrosis in Mice
Abstract Number: 433

Bronchiectasis: A Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis
Abstract Number: 2752

Budd-Chiari Syndrome Due to Behçet’s Syndrome: Some Patients Present without Liver Related Symptoms and Have a Better Outcome
Abstract Number: 2125

Burden of Illness in Refractory Gouty Arthritis: A One-Year Prospective Multinational, Observational Study

Jump to: View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z